# AnPac Bio-Medical Science Co., Ltd. — Form D

AnPac Bio-Medical Science Co., Ltd. of Lishui, F4, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-27. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-05-27
- Form: D
- Accession: 0001104659-22-065976
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.4M
- Investors: 1
- Date of first sale: 2022-05-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-447385

## Issuer

- Name: AnPac Bio-Medical Science Co., Ltd.
- CIK: 0001786511
- Entity type: Corporation
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Address: 801 BIXING STREET, BIHU COUNTY, Lishui, F4, 323006
- Phone: +86-5782-051-6666

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| Chang Yu | Director | Lishui, F4 |
| Chang Yu | Executive Officer | Lishui, F4 |
| Lin Yu | Director | Irvine, CA |
| Edward Tang | Executive Officer | San Mateo, CA |
| Aidong Chen | Director | Lishui, F4 |
| Aidong Chen | Executive Officer | Lishui, F4 |
| Jianhua Shao | Director | Lishui, F4 |
| Jinqiu Tang | Executive Officer | Lishui, F4 |
| Pu Xing | Director | Lishui, F4 |
| Chris Chang Yu | Director | Lishui, F4 |
| Chris Chang Yu | Executive Officer | Lishui, F4 |
| He Yu | Executive Officer | Lishui, F4 |
| Ren Luo | Director | Lishui, F4 |
| Feng Guo | Director | Lishui, F4 |
| Sheng Liu | Director | Lishui, F4 |
| XueDong Du | Executive Officer | Lishui, F4 |
| Weidong Dai | Executive Officer | Lishui, F4 |
| Sarah Yu | Director | Lishui, F4 |
| Jiefeng Gu | Executive Officer | Lishui, F4 |
| Yu Chris | Director | Lishui, F4 |
| Yu Chris | Executive Officer | Lishui, F4 |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-13](https://search.stillhousedata.com/formd/0001104659-22-070317) | D | $1.5M | $1.5M |
| [2022-06-13](https://search.stillhousedata.com/formd/0001104659-22-070311) | D | $1.5M | $1.5M |
| [2020-08-24](https://search.stillhousedata.com/formd/0001104659-20-097978) | D | $265K | $265K |

## More

- [CIK 1786511 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1786511&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-22-065976.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.